Md Saifur Rahman Khan
Has grant
Director, Bioinformatics and Metabolomics Unit, The Center for Immunometabolism
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Recent Grants
Grant: Close
The discovery of novel predictive biomarkers and early-stage pathophysiology for the transition from gestational diabetes to type 2 diabetes
Open Date: 2019-06-01
Close Date:
Grant: Close
Transition of type 2 diabetes from gestational diabetes mellitus: Prediction with high discrimination and novel insight of the type 2 diabetes etiology
Open Date: 2017-08-01
Close Date: 2020-07-01
Grant: Close
Mode of action of isoniazid
Open Date: 2015-09-01
Close Date:
Grant: Close
Mechanism of isoniazid-induced agranulocytosis using omics platforms
Open Date: 2012-09-01
Close Date: 2015-08-01
Grant: Close
NA
Open Date: 2011-09-01
Close Date: 2013-08-01
Articles (4)
Gestational diabetes mellitus (GDM), a transient form of diabetes that resolves postpartum, is a major risk factor for type 2 diabetes (T2D) in women. While the progression from GDM to T2D is not fully understood, it involves both genetic and environmental components. By integrating clinical, metabolomic, and genome-wide association study (GWAS) data, we identified associations between decreased sphingolipid biosynthesis and future T2D, in part through the rs267738 allele of the CERS2 gene in Hispanic women shortly after a GDM pregnancy. To understand the impact of the CERS2 gene and risk allele on glucose regulation, we examined whole-body Cers2 knockout and rs267738 knock-in mice. Both models exhibited glucose intolerance and impaired insulin secretion in vivo. Islets isolated from these models also demonstrated reduced β cell function, as shown by decreased insulin secretion ex vivo. Overall, reduced circulating sphingolipids may indicate a high risk of GDM-to-T2D progression and reflect deficits in CERS2 activity that negatively affect glucose homeostasis and β cell function.
Year:
2025
Aims Gestational diabetes mellitus (GDM) poses a significant risk for developing type 2 diabetes mellitus (T2D) and exhibits heterogeneity. However, understanding the link between different types of post‐GDM individuals without diabetes and their progression to T2D is crucial to advance personalised medicine approaches. Materials and Methods We employed a discovery‐based unsupervised machine learning clustering method to generate clustering models for analysing metabolomics, clinical, and biochemical datasets. For this analysis, we selected 225 women who later developed T2D during the 12‐year follow‐up period from the cohort of 1010 women who returned to a non‐diabetic state at 6–9 weeks (study baseline) after a GDM pregnancy based on 2‐h 75 g research OGTTs. The optimal model was selected by assessing Bayesian Information Criterion values, class separation performance, and the potential for clinically distinguishable clusters, accounting for participant prenatal and early postpartum characteristics. Results The selected model comprises three clusters: pancreatic beta cell dysfunction (cluster‐β: median HOMA‐B 161.3 and median HOMA‐IR 3.8), insulin‐resistance (cluster‐IR: median HOMA‐B 630.5 and median HOMA‐IR 16.8), and a mixed cluster (cluster‐mixed: median HOMA‐B 307.2 and median HOMA‐IR 8.6). These clusters are distinguishable based on postpartum blood test parameters such as glucose tolerance, HOMA indices, and fasting lipid profiles including triglycerides, leptin, HDL‐c, and adiponectin, as well as participant age and BMI. Metabolomic analysis identified unique molecular signatures for each cluster. However, the time to T2D onset was not statistically significant among the three clusters ( p = 0.22). Conclusion This study enhances our understanding of the heterogeneity of early postpartum metabolic profiles that characterise the future onset of T2D diabetes in a diverse cohort of women with GDM, revealing insights into distinct mechanisms and personalised intervention strategies for the prevention of T2D.
Year:
2025
Year:
2023
Year:
2023
Collaborators (4)
Babak Razani
Chief of Cardiology
VA Pittsburgh Healthcare System
Julie Van
University of Toronto
Scott Summers
Co-Director
University of Utah
Michael B Wheeler
Professor
University of Toronto
Make your next move.
Prepare your application
Review drafts before you send them.